Vivos Therapeutics (NASDAQ:VVOS) Trading Up 6.9% – Still a Buy?

Vivos Therapeutics, Inc. (NASDAQ:VVOS)’s share price shot up 6.9% during trading on Friday . The stock traded as high as $5.12 and last traded at $4.98. 227,933 shares were traded during mid-day trading, a decline of 50% from the average session volume of 458,018 shares. The stock had previously closed at $4.66.

Analyst Ratings Changes

Several research firms have recently weighed in on VVOS. Ascendiant Capital Markets restated a “buy” rating and set a $6.60 price target on shares of Vivos Therapeutics in a report on Wednesday, November 20th. Alliance Global Partners reduced their target price on shares of Vivos Therapeutics from $8.25 to $6.00 and set a “buy” rating on the stock in a report on Tuesday, November 19th.

Vivos Therapeutics Stock Performance

The company has a fifty day simple moving average of $3.34 and a 200 day simple moving average of $2.81. The stock has a market capitalization of $24.08 million, a price-to-earnings ratio of -0.88 and a beta of 7.67.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.